Abstract
Intraoperative use of transesophageal echocardiography (TEE) has become commonplace in high-risk noncardiac surgeries but the balance of benefits and harms remains unclear. This systematic review investigated the comparative effectiveness and harms of intraoperative TEE in noncardiac surgery. We searched Ovid MEDLINE, PubMed, EMBASE, and the Cochrane Library from 1946 to March 2017. Two reviewers independently screened the literature for eligibility. Studies were assessed for the risk of selection bias, confounding, measurement bias, and reporting bias. Three comparative and 13 noncomparative studies were included. Intraoperative TEE was employed in a total of 1912 of 3837 patients. Studies had important design limitations. Data were not amenable to quantitative synthesis due to clinical and methodological diversity. Reported incidence of TEE complications ranged from 0% to 1.7% in patients undergoing various procedures (5 studies, 540 patients). No serious adverse events were observed for mixed surgeries (2 studies, 197 patients). Changes in surgical or medical management attributable to the use of TEE were noted in 17% to 81% of patients (7 studies, 558 patients). The only randomized trial of intraoperative TEE was grossly underpowered to detect meaningful differences in 30-day postoperative outcomes. There is lack of high-quality evidence of effectiveness and harms of intraoperative TEE in the management of non-cardiac surgeries. Evidence, however, indicates timely evaluation of cardiac function and structure, and hemodynamics. Future studies should be comparative evaluating confounder-adjusted impact on both intraoperative and 30-day postoperative clinical outcomes.
Keywords
Introduction
Transesophageal echocardiography (TEE) in cardiac surgery has evolved beyond its original use to assess global ventricular systolic function, regional wall motion abnormalities, and severity of valvular lesions.1-3 It is now increasingly used intraoperatively to monitor hemodynamic status, examine cardiac structures, confirm diagnoses, and assess early results of surgical interventions. Furthermore, the technology has now expanded into non-cardiac perioperative settings as a natural extension of its use in cardiac surgery.
With the diminishing use of the pulmonary artery catheter, 4 anesthesiologists need real-time dynamic monitoring modalities to optimize perioperative hemodynamic management and minimize perioperative morbidity and mortality. Mortality rates following elective noncardiac surgery have not significantly improved over the past 25 years despite advances in preoperative risk assessment, introduction of enhanced recovery programs, and advances in minimally invasive surgical procedures.5-7 As such, both transthoracic echocardiography (TTE) and TEE are now integrated widely into daily anesthesia practice.8-11 However, the sterile surgical field, positive pressure ventilation, patient’s position, and inaccessibility of the standard acoustic windows limit the intraoperative use of TTE. TEE, therefore, becomes a more practical modality for intraoperative cardiac imaging and hemodynamic monitoring.
The only systematic review on the topic investigated the frequency distribution of various pathologies detected with point of care echocardiography in patients undergoing noncardiac surgery. 11 The review, however, neither performed a critical appraisal of the literature nor investigated the effectiveness and harms of TEE.
To investigate the comparative effectiveness and harms of the intraoperative use of TEE in noncardiac surgery and identify subgroups of patients most likely to benefit, we performed a systematic review of the literature. Initially, when we searched and screened the literature, the scope of literature review was wider including the evidence for TEE training requirements, certification and maintenance of competence. In this article, however, we report evidence synthesis for comparative effectiveness and harms of intraoperative TEE in noncardiac surgery.
Methods
We followed the Cochrane and PRISMA standards for conducting and reporting our systematic review.12,13
Data Sources
An experienced information specialist searched Ovid MEDLINE, PubMed, EMBASE, and the Cochrane Library from 1946 to March 2017. An additional search was conducted using the Google search engine. Keywords and medical subject headings related to TEE, perioperative/intraoperative period and noncardiac surgery were used. Retrieved records were limited to English language and human studies. The full search strategy is provided in the supplementary material (available in the online version of the article).
Study Selection
We included both experimental or observational studies that employed TEE intraoperatively to manage noncardiac surgery. To detect publication bias, we did not exclude studies when they did not report outcomes of unintended harms of TEE, intraoperative clinical events (mortality, cardiac arrest, myocardial infraction), change in patient management, and postoperative 30-day clinical events (mortality, cardiovascular mortality, myocardial infraction, stroke/transient ischemic attack, arrhythmia, hypotension requiring circulatory support, acute kidney injury and length of hospital stay) which were considered the review outcomes of interest.
We excluded records:
with study participants that were not adult noncardiac surgical patients
when intervention was not TEE
when effectiveness or harms of intraoperative TEE, reporting of TEE findings, or TEE training, assessment and certification were not investigated
when they were editorials, commentaries, narrative reviews, case reports, or surveys of views of health care providers
when they were reported in a language other than English
for other reasons as documented in the PRISMA flow diagram (Figure 1)

PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram for the review.
One reviewer screened titles (AF) and excluded ineligible records. Another reviewer independently confirmed exclusions (MTA). Full texts of included records were further assessed for eligibility independently by 2 reviewers (AF and MTA). Disagreements were resolved with consensus. General study characteristics and outcomes data were extracted by one reviewer (MTA) and verified by another reviewer (AF). Between reviewers, both methods and content expertise were represented.
Critical Appraisal
Because much methodological diversity was anticipated, we employed a generic assessment of methodological limitations when critically appraising the studies (risk of bias assessment). We evaluated studies for selection bias (including attrition bias), confounding, measurement bias, and obvious outcome reporting bias. Inferences about effectiveness and harms of therapeutic or diagnostic interventions require assessment of the validity of studies for causal inference; in other words, establishing that the exposure or intervention and outcome associational risk estimate represents the causal risk estimate. Noncomparative single arm before-after studies have serious limitations in this regard unless effect sizes are very large and there are no other plausible competing explanations (eg, confounder effect). Plausible and competing explanations for observed effects in single-arm before-after trials, cohorts, and case-series can be attributed to time-dependent natural variation in disease severity, patient prognostic factors, co-exposures and co-interventions. We could not undertake a formal assessment of outcome reporting bias because study protocols did not exist or were not accessible. Publication bias could also not be detected because data were not amenable to quantitative synthesis (see below).
Evidence Synthesis
Clinical and methodological diversity across studies and sparse data precluded data meta-analysis. Furthermore, most studies were noncomparative and descriptive in design rather than analytic from which no estimates of effects could be generated. We, therefore, adopted a qualitative approach to evidence synthesis.
Results
We screened 1329 records and included 16 studies of effectiveness and harms of intraoperative TEE in non-cardiac surgery (Figure 1). Intraoperative TEE was used in 1912 of 3837 patients included across the entire body of evidence (Table 1). Only three studies were comparative analyses: a randomized controlled trial and 2 cohort studies, with the remaining studies employing single-arm cohort or experimental design (Table 2).14-16
Included Study Characteristics.
Abbreviations: NR, not reported; RCT, randomized controlled trial.
“Mixed” indicates that different types of surgery that may have included obstetrics, gynecological procedures, general surgery, orthopedic procedures, neurosurgery, lung transplant, urology, or plastic procedures.
Included Study Designs and Reported Outcomes.
Abbreviations: NR, not reported; TEE, transesophageal echocardiography; ASA, American Society of Anesthesiologists; SCA, Society of Cardiovascular Anesthesiologists.
Study Risk of Bias
We found serious study limitations in all non-comparative evidence. Even the three comparative studies were not free of important design limitations. Important concerns were confounding by indication and detection or selection bias (Table 3). Furthermore, only 4 studies examined postoperative adverse clinical outcomes (see section “Thirty-Day Postoperative Clinical Outcomes”), indicating a shortage of empiric evidence addressing the topic of interest.15,17-19
Effectiveness and Harms of Intraoperative Transesophageal Echocardiography (TEE) in Noncardiac Surgery.
TEE Probe–Related Complications
Nine studies reported complications associated with intraoperative TEE in noncardiac surgical populations.14-16,19-24 In 2 studies, only serious TEE complications were measured.21,23 Zero cases were reported for 197 patients. Of 5 studies investigating all TEE-related complications, 3 cases were reported across 540 patients with incidence ranging from 0% to 1.7%.14,15,20,22,24 Incidence of gastrointestinal bleeds associated with probe insertion in patients undergoing liver transplantation ranged from 0.3% to 2.5%.14,16,19,22 Complications such as odynophagia, oropharyngeal and dental trauma, esophageal perforation, and endotracheal tube displacement requiring repositioning were not found.
No adverse TEE probe–related adverse events were observed in the single randomized controlled trial in which 14 surgical patients were assigned to TEE-guided intraoperative hemodynamic management versus 14 to routine care. 15 Two other comparative observational studies were also underpowered to detect any significant differences in specific probe-related complications between patients managed with intraoperative TEE versus patients who were not.14,16
Intraoperative Clinical Events
Changes in or emerging clinical events were rarely reported across studies. Twelve intraoperative deaths were reported in 140 surgical patients in four non-comparative studies.17,18,25,26 These numbers, however, do not lend themselves to even a crude estimation of TEE-associated risk of death because 2 of the 4 studies were case series of patients who had experienced cardiac arrest intraoperatively.17,26
Change in Intraoperative Management
Seven noncomparative studies including a total of 558 patients contributed relevant data.17,20,21,23,24,27,28 The intraoperative surgical or medical management was altered because of TEE probe placement was a subjective nonblinded assessment of investigators. After excluding 2 studies, the study by Memtsoudis et al 17 (which was restricted to a series of patients experiencing intraoperative cardiac arrest) and the study by Black et al 20 (which exclusively focused on the management of paradoxical air embolism in neurosurgical patients), changes in surgical or medical management attributable to the use of TEE were noted in 17% to 81% of heterogeneous samples of noncardiac surgical patient population. All contributing studies had serious study design limitations for causal inference (Table 3).
Thirty-Day Postoperative Clinical Outcomes
Four studies observed the postoperative course of patients (Table 3)15,17-19 The study by Memtsoudis et al 17 observed that 32% of 22 noncardiac surgical patients who underwent intraoperative TEE examination because of unexpected hemodynamic collapse requiring advanced cardiac life support subsequently died in the immediate postoperative period. The study was a retrospective and noncomparative evaluation of a departmental TEE database for which it was difficult to make judgements about the presence or absence of selection bias due to inadequate reporting. Furthermore, generalizability of the findings is very limited. No other postoperative clinical events were reported in this study. In another noncomparative study of 396 patients undergoing liver transplantation under intraoperative TEE monitoring, 4% of patients died within 30 days. 19
Shillcutt et al 18 conducted a retrospective cohort study of patients undergoing orthotopic liver transplantation. Authors aimed to investigate associations between intraoperative TEE findings and postoperative clinical outcomes, but the study was not designed to evaluate effectiveness of TEE. Most common intraoperative TEE findings were microemboli (44% of patients), right ventricular dysfunction (31%), and thromboembolism (27%). Biventricular dysfunction and intracardiac thromboemboli were associated with decreased overall 1-year survival and 30-day major adverse cardiovascular events.
Shillcutt et al 15 reported a randomized controlled trial in 28 patients with left ventricular diastolic dysfunction at increased risk of postoperative adverse events. The study was clearly underpowered for clinical outcomes. Within 30 days after surgery, 2 patients randomized to intraoperative TEE developed congestive heart failure or atrial fibrillation. In the conventional management arm (intraoperative noninvasive blood pressure monitoring or invasive arterial line or central venous line), the corresponding number of patients was 6 (relative risk = 0.33, 95% CI 0.08-1.38). Postoperative myocardial infarction, stroke/transient ischemic attack, and acute kidney injury were not observed. Length of hospital stay did not significantly differ between the randomized groups. Mortality outcome was not reported.
Discussion
Practice guidelines and expert opinion recommend the use of TEE to manage patients undergoing cardiac surgical procedures. 29 For noncardiac surgeries, although early reports indicated TEE’s incremental clinical value in noncardiac surgical patients and superiority over other monitoring modalities, a critical review of existing evidence has been lacking.30-32
To our knowledge, this is the first systematic and critical evaluation of the literature addressing the question of effectiveness and harms of the use of intraoperative TEE exclusively in patients undergoing noncardiac surgical procedures when compared with management without the use of this technology. While authors of included studies concluded that the use of TEE is effective and safe for intraoperative management of high-risk patents, our findings could not confirm this claim for a number of reasons. Despite the fact that our systematic review included evidence from well more than 3000 patients, we conclude that there is a lack of high-quality evidence addressing the comparative effectiveness and harms of intraoperative TEE in the management of noncardiac surgical procedures versus routine intraoperative hemodynamic monitoring. Extant evidence does however suggest that the technology aids in a timely evaluation of functional and morphological cardiac parameters, and hemodynamics.
A number of factors contribute to the inconclusive findings of this review. With rare exceptions, generally studies were not analytically designed and analyzed to study effectiveness and harms of TEE in comparison with routine intraoperative hemodynamic management—only 3 of 16 studies employed a comparative design.14-16 As such, various design and analytic biases were noted precluding confident conclusions about the relative effectiveness and safety of the intervention. Also, a number of studies were restricted to specific noncardiac surgical populations, for example, posterior fossa neurosurgical procedures in the sitting position, orthotopic liver transplantation, or patients experiencing intraoperative cardiac arrest, limiting generalizability of findings. Furthermore, postoperative outcomes were rarely investigated, and when they were, studies lacked statistical power to detect important differences.
Jasudavisius et al 11 recently published a systematic review of TEE in noncardiac surgery. Comparative effectiveness in terms of differences in risk of adverse surgical outcomes between the use and nonuse of TEE intraoperatively was not investigated. Rather, authors provided a prevalence map of the various diagnoses reported across the studies employing TTE or TEE in the perioperative period. Across 13 included studies, they found that the most common intraoperative findings were low ejection fraction, right ventricular failure, wall motion abnormalities, and pulmonary embolism. Our findings confirm their observation that currently there is lack of evidence demonstrating the effectiveness of intraoperative TEE in improving patient-oriented outcomes.
Of the 12 practice guidelines on the use of perioperative TEE published to date (Table 4), only 3 examined existing evidence and found it to be of limited quality with recommendations largely founded on expert opinion.29,33,34 In our view, despite uncertainty about the comparative effectiveness and harms of TEE, existing guidance, even when largely based on expert opinion, is necessary as the technology has already diffused into routine noncardiac surgical practice. In this light, current guideline recommendations limiting the use of TEE to high-risk noncardiac surgeries and patients with intraoperative hemodynamic instability appear to be reasonable. Our review highlights the limitations of evidence and calls for high-quality research on the topic to establish empirically that benefits of TEE outweigh harms and costs in managing high-risk noncardiac surgical procedures. Ever increasing scarcity of health care resources makes it imperative that recommendations for intraoperative use of TEE in noncardiac surgeries are based on high certainty evidence of benefits outweighing risks and burden to the patient, the operating team, or both, and the cost to the health system and payers.
Published TEE Guidelines.
Abbreviations: ASA, American Society of Anesthesiologists; ASE, American Society of Echocardiography; SCA, Society of Cardiovascular Anesthesiologists; TEE, Transesophageal echocardiography.
Clinical thinking at the point of care is focused on structural, morphological and hemodynamic changes. While there is validity of TEE in intraoperative settings for identifying hemodynamic instability and its etiology, our review shows that there is dearth of high-quality empiric evidence of the effectiveness and cost-effectiveness of TEE in improving outcomes of surgery such as length of hospital stay and 30-day postoperative events. Despite the passage of time, unfortunately, the observation by Catena and Mele 35 that little literature exists on patient outcome, logistics, financial impact, medicolegal implications, and safety of TEE in noncardiac surgeries remain true today.
Limitations of our review include language restriction as one of the study eligibility criteria and the lack of formally grading our certainty in findings as per the GRADE (Grading of Recommendations, Assessment, Development and Evaluations) approach. 36 The latter, however, was a deliberate decision of ours as the limitations in the design, statistical power, validity and applicability of studies were quite obvious, obviating a formal GRADE evaluation.
Ideally, adequately randomized controlled trials are best suited to study effectiveness, cost-effectiveness, and harms of interventions. However, given the quality of existing studies on the topic we have observed in this systematic review of the literature, large administrative database analyses, including interrupted time series, that adequately control for confounding and patient selection bias appear to be the most practical way forward as future research agenda. Furthermore, prospective studies should not only investigate intraoperative clinical outcomes but also 30-day postoperative clinical events.
Footnotes
Acknowledgements
We would like to thank Alexandra (Sascha) Davis BA, MLIS, Librarian, Library and Learning Centre, Civic Campus, The Ottawa Hospital for developing the search strategy for this review.
Declaration of Conflicting Interests
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article:
Dr. Fayad is an author for UpToDate and receives authorship bonus.
Dr. Shillcutt is an author for
, has funding from the National Institute of Aging (1R03 AG045103-01A1), and is owner of Brave Enough, LLC.
Dr. Ansari received payment from lead author for his work as a senior meta-research methodologist on this project.
None declared for other co-authors.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
Supplemental Material
Supplementary material is available for this article online.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
